Conference Reports for NATAP

Back

8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV     Risk Factors for Bone Loss in HIV Appear to be Associated with Weight Loss and Additional Risk Factors Found in General Population - (01/12/07)   Genetic Basis for Body Fat Loss - (01/12/07)   Improved Triglycerides and Insulin Sensitivity with 3 mos of Acipimox in HIV-infected Patients with Hypertriglyceridemia - (10/24/06)   Comparison of the Effects on Body Composition of Rosiglitazone, Pravastatin, and Growth Hormone Alone and in Combination in the HIV-associated Lipoatrophy Treatment (HALT) Study - (10/17/06)   Mitochondrial function, morphology, and metabolic parameters improve after switching from a stavudine- to a tenofovir-containing regimen: SNAP (Switch Nucleoside Analogues Protocol) - (10/17/06)   Anti-inflammatory effects on body composition and metabolic alterations in HIV lipodystrophy: a pilot study - (10/17/06)   Switching to lopinavir/ritonavir (LPV/r) Tablets once daily (TAB-QD) from soft-gel capsule dosed BID/QD (SGC-BID/SGC-QD) led to significant improvements in tolerability, diarrhea, antidiarrheal medication use, and satisfaction - (10/01/06)   Significant Improvements in Self-Reported Gastrointestinal Tolerability, Quality of Life, Patient Satisfaction, and Adherence with Lopinavir/ritonavir After Switching from BID Soft-Gel Capsules (SGC) to BID Tablets - (09/28/06)   A six-months ART interruption in HIV-infected patients improves adipose tissue morphology and gene expression (ANRS EP29 Lipostop) - (09/28/06)   Leptin Improves Visceral Belly Fat, Dyslipidemia, and Insulin Resistance - (09/28/06)   Pioglitazone Improves Limb Fat Loss - (09/26/06)   Systemic Errors in Estimating Renal Function by Cockroft-Gault or MDRD Equations - (09/26/06)   Improvement in Insulin Sensitivity and Dyslipidemia in Protease Inhibitor-Treated Patients After Switch to Atazanavir/Ritonavir (ATV/RTV): A Prospective Study Using Hyperinsulinemic, Euglycemic Clamp Testing - (09/26/06)   Risk of Hepatotoxicity in Virologically Suppressed HIV+ Patients switching to Nevirapine According to Gender & CD4 Count - (09/26/06)   Limb Fat Loss: nelfinavir, efavirenz, nukes - (09/26/06)